Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CytoDyn Inc.CYDY · Entity 5856 | Director | June 25, 2020 | June 27, 2020 |
| Rezolute, Inc.ANTB · Entity 1990 | Director | March 08, 2017 | March 15, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CytoDyn Inc.
Report date June 25, 2020 · Filed June 27, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.15 · Expires 2030-06-25 | Direct | 225,000 |
Reported balance
After 2020-06-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-25 · Grant · Acquired 225,000 · Balance 225,000 F1: 56,250 shares vest on August 31, 2020; the balance vests in equal amounts on November 30, 2020, February 28, 2021 and May 31, 2021, subject to amendment to the equity incentive plan. |
Filing footnotes · ownership attribution and instrument terms
F1: 56,250 shares vest on August 31, 2020; the balance vests in equal amounts on November 30, 2020, February 28, 2021 and May 31, 2021, subject to amendment to the equity incentive plan.
Rezolute, Inc.
Report date March 08, 2017 · Filed March 15, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy LRFA | 1,811,415 |
Last balance in matching sequence
After 2017-03-10 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 3 · 2017-03-08 · Purchase · Acquired 5,000 · Balance 1,801,415 F2: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC. Row 4 · 2017-03-09 · Purchase · Acquired 5,000 · Balance 1,806,415 F2: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC. Row 5 · 2017-03-10 · Purchase · Acquired 5,000 · Balance 1,811,415 F2: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC. |
| Common StockSEC Table I · non-derivative | IndirectBy Welch Group | 28,100 |
Reported balance
Holding disclosure · report date 2017-03-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 28,100 F1: The Reporting Person is General Partner of Welch Group, LP and has voting and dispositive power of the shares of the Issuer's common stock owned by Welch Group, LP. |
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2017-03-08 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person is General Partner of Welch Group, LP and has voting and dispositive power of the shares of the Issuer's common stock owned by Welch Group, LP.
F2: The Reporting Person is President of LRFA, LLC and has voting and dispositive power of the shares of the Issuer's common stock owned by LRFA, LLC.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Infinera Corp
Report date February 28, 2025 · Filed March 03, 2025
Section 16 reporting ended · disclosed 2025-03-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 532,871 |
Reported balance
After 2025-02-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-02-28 · Exercise / conversion · Acquired 100,001 · Balance 532,871 F1: Shares of Company common stock reported are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2025-02-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-02-28 · Disposition to issuer · Disposed 532,871 · Balance 0 F2: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 27, 2024, by and among Nokia Corporation, Neptune of America Corporation and Infinera Corporation ("Company"), referred to as the "Merger Agreement". F3: Each share of Company common stock held by the Reporting Person was automatically cancelled, extinguished and converted into the right to receive the consideration provided in the Merger Agreement. F1: Shares of Company common stock reported are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which the Reporting Person is a trustee. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2025-02-28 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2025-02-28 · Disposition to issuer · Disposed 2,500 · Balance 0 F2: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 27, 2024, by and among Nokia Corporation, Neptune of America Corporation and Infinera Corporation ("Company"), referred to as the "Merger Agreement". F3: Each share of Company common stock held by the Reporting Person was automatically cancelled, extinguished and converted into the right to receive the consideration provided in the Merger Agreement. F4: Shares of Company common stock held directly by the Reporting Person as a trustee for his children. The Reporting Person disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-02-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-02-28 · Exercise / conversion · Disposed 100,001 · Balance 0 F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. F6: Includes shares of Company common stock underlying previously reported unvested RSUs which immediately prior to the Effective Time (as defined in the Merger Agreement) of the merger fully vested and converted automatically into the right to receive the consideration provided in the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Company common stock reported are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which the Reporting Person is a trustee.
F2: Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of June 27, 2024, by and among Nokia Corporation, Neptune of America Corporation and Infinera Corporation ("Company"), referred to as the "Merger Agreement".
F3: Each share of Company common stock held by the Reporting Person was automatically cancelled, extinguished and converted into the right to receive the consideration provided in the Merger Agreement.
F4: Shares of Company common stock held directly by the Reporting Person as a trustee for his children. The Reporting Person disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.
F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F6: Includes shares of Company common stock underlying previously reported unvested RSUs which immediately prior to the Effective Time (as defined in the Merger Agreement) of the merger fully vested and converted automatically into the right to receive the consideration provided in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 06, 2021 Filed Dec 7, 2021 20:27 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 3,099 | $8.07 | $25,008.93 |
DisclosureSEC source: 0001138639-21-000211 · wf-form4_163892685440797.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 700,268 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 20:27 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000211 · wf-form4_163892685440797.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 703,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 05, 2021 Filed Dec 7, 2021 20:27 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000211 · wf-form4_163892685440797.xml · derivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 37,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F4 · derivative.exercise_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F4 · derivative.expiration_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| October 05, 2021 Filed Oct 6, 2021 21:24 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 44,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000186 · wf-form4_163356987142558.xml · derivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,556 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F4 · derivative.exercise_date: On March 27, 2019, Dr. Welch was granted a PSU award for a target number of 50,000 shares of common stock that could become eligible to vest subject to the Company's achievement of positive operating income (the "Performance Goal") during fiscal 2019 through fiscal 2021. The Performance Goal is measured on a non-GAAP basis, either (a) for a full fiscal year or (b) for any four consecutive fiscal quarters. The Company achieved the Performance Goal during the four consecutive fiscal quarters ending with the fiscal quarter ended June 26, 2021, as certified by the Company's Compensation Committee on September 13, 2021, per the terms of the PSU award. As a result, 44,444 shares of common stock underlying this award will vest on October 5, 2021 and 5,556 shares of common stock underlying this award will vest on January 5, 2022, each vesting subject to Dr. Welch's continued service to the Company through such date. F4 · derivative.expiration_date: On March 27, 2019, Dr. Welch was granted a PSU award for a target number of 50,000 shares of common stock that could become eligible to vest subject to the Company's achievement of positive operating income (the "Performance Goal") during fiscal 2019 through fiscal 2021. The Performance Goal is measured on a non-GAAP basis, either (a) for a full fiscal year or (b) for any four consecutive fiscal quarters. The Company achieved the Performance Goal during the four consecutive fiscal quarters ending with the fiscal quarter ended June 26, 2021, as certified by the Company's Compensation Committee on September 13, 2021, per the terms of the PSU award. As a result, 44,444 shares of common stock underlying this award will vest on October 5, 2021 and 5,556 shares of common stock underlying this award will vest on January 5, 2022, each vesting subject to Dr. Welch's continued service to the Company through such date. Read SEC document |
| October 05, 2021 Filed Oct 6, 2021 21:24 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 22,036 | $8.27 | $182,237.72 |
DisclosureSEC source: 0001138639-21-000186 · wf-form4_163356987142558.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 697,117 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| October 05, 2021 Filed Oct 6, 2021 21:24 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 44,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000186 · wf-form4_163356987142558.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 719,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 18:53 UTC | Infinera Corp INFN · Entity 82602 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000172 · wf-form4_163174641563043.xml · derivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F2 · derivative.exercise_date: On March 27, 2019, Dr. Welch was granted a PSU award for a target number of 50,000 shares of common stock that could become eligible to vest subject to the Company's achievement of positive operating income (the "Performance Goal") during fiscal 2019 through fiscal 2021. The Performance Goal is measured on a non-GAAP basis, either (a) for a full fiscal year or (b) for any four consecutive fiscal quarters. The Company achieved the Performance Goal during the four consecutive fiscal quarters ending with the fiscal quarter ended June 26, 2021, as certified by the Company's Compensation Committee on September 13, 2021, per the terms of the PSU award. As a result, 44,444 shares of common stock underlying this award will vest on October 5, 2021 and 5,556 shares of common stock underlying this award will vest on January 5, 2022, each vesting subject to Dr. Welch's continued service to the Company through such date. F2 · derivative.expiration_date: On March 27, 2019, Dr. Welch was granted a PSU award for a target number of 50,000 shares of common stock that could become eligible to vest subject to the Company's achievement of positive operating income (the "Performance Goal") during fiscal 2019 through fiscal 2021. The Performance Goal is measured on a non-GAAP basis, either (a) for a full fiscal year or (b) for any four consecutive fiscal quarters. The Company achieved the Performance Goal during the four consecutive fiscal quarters ending with the fiscal quarter ended June 26, 2021, as certified by the Company's Compensation Committee on September 13, 2021, per the terms of the PSU award. As a result, 44,444 shares of common stock underlying this award will vest on October 5, 2021 and 5,556 shares of common stock underlying this award will vest on January 5, 2022, each vesting subject to Dr. Welch's continued service to the Company through such date. Read SEC document |
| September 05, 2021 Filed Sep 8, 2021 20:33 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000170 · wf-form4_163114756885482.xml · derivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 43,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F4 · derivative.exercise_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F4 · derivative.expiration_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| September 05, 2021 Filed Sep 8, 2021 20:33 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 3,099 | $8.84 | $27,395.16 |
DisclosureSEC source: 0001138639-21-000170 · wf-form4_163114756885482.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 674,709 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| September 05, 2021 Filed Sep 8, 2021 20:33 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000170 · wf-form4_163114756885482.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 677,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 19:14 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000129 · wf-form4_162319407359852.xml · derivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F4 · derivative.exercise_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Mr. Welch's continued service to the Company through each applicable vesting date. F4 · derivative.expiration_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Mr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 19:14 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 3,099 | $10.24 | $31,733.76 |
DisclosureSEC source: 0001138639-21-000129 · wf-form4_162319407359852.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 671,558 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 19:14 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000129 · wf-form4_162319407359852.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 674,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 14,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · derivative · entry 13 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,549 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F7 · derivative.exercise_date: On February 15, 2018, Dr. Welch was granted a PSU award for a target number of 45,833 shares of common stock that could become eligible to vest in three equal separate installments, subject to the achievement of certain performance criteria in each of the three different performance periods. The shares were eligible to vest based on the TSR performance of the Company in each performance period relative to that of the companies that comprise the S&P Networking Index. The performance objective related to this award was partially achieved for the third performance period, as determined by the Company's Compensation Committee per the terms of the original grant, resulting in an RSU award of 14,549 shares that was subject to time-based vesting. This time-based vesting was satisfied on May 5, 2021. The Form 4 filed on March 11, 2021 with respect to the performance vesting of the PSU award erroneously stated that the RSU award was for 14,550 shares. F7 · derivative.expiration_date: On February 15, 2018, Dr. Welch was granted a PSU award for a target number of 45,833 shares of common stock that could become eligible to vest in three equal separate installments, subject to the achievement of certain performance criteria in each of the three different performance periods. The shares were eligible to vest based on the TSR performance of the Company in each performance period relative to that of the companies that comprise the S&P Networking Index. The performance objective related to this award was partially achieved for the third performance period, as determined by the Company's Compensation Committee per the terms of the original grant, resulting in an RSU award of 14,549 shares that was subject to time-based vesting. This time-based vesting was satisfied on May 5, 2021. The Form 4 filed on March 11, 2021 with respect to the performance vesting of the PSU award erroneously stated that the RSU award was for 14,550 shares. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 28,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · derivative · entry 12 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,707 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F6 · derivative.exercise_date: These RSUs vest in four annual installments beginning on May 5, 2018, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F6 · derivative.expiration_date: These RSUs vest in four annual installments beginning on May 5, 2018, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 17,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · derivative · entry 11 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,187 Underlying: Common Stock · 17,187 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F5 · derivative.exercise_date: These RSUs vest in three annual installments beginning on May 5, 2019, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F5 · derivative.expiration_date: These RSUs vest in three annual installments beginning on May 5, 2019, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · derivative · entry 10 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 33,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F4 · derivative.exercise_date: These RSUs vest in three annual installments beginning on May 5, 2020, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F4 · derivative.expiration_date: These RSUs vest in three annual installments beginning on May 5, 2020, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 5,032 | $8.58 | $43,174.56 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 8 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 668,407 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 14,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 7 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 673,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 9,927 | $8.58 | $85,173.66 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 6 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 658,890 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 28,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 5 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 668,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 5,944 | $8.58 | $50,999.52 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 640,110 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 17,187 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 3 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 646,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 11,778 | $8.58 | $101,055.24 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 628,867 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| May 05, 2021 Filed May 7, 2021 19:02 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000080 · wf-form4_162042851539529.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 640,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| March 16, 2021 Filed Mar 25, 2021 18:01 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 80,622 | $10.15 | $818,192.37 |
DisclosureSEC source: 0001138639-21-000065 · wf-form4_161670969616462.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 607,312 F1 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F2 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $10.00 to $10.25 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 18:38 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 419,378 | $10.05 | $4,216,132.85 |
DisclosureSEC source: 0001138639-21-000063 · wf-form4_161602063859911.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 687,934 F1 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F2 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $9.715 to $10.215 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 18:57 UTC | Infinera Corp INFN · Entity 82602 | GrantRestricted Stock Units · Derivative | 33,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000052 · wf-form4_161550704913652.xml · derivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,800 Underlying: Common Stock · 33,800 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F3 · derivative.exercise_date: These RSUs vest as to one-half of the shares on the one-year anniversary of the vesting commencement date, which is April 5, 2021, and 1/8th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F3 · derivative.expiration_date: These RSUs vest as to one-half of the shares on the one-year anniversary of the vesting commencement date, which is April 5, 2021, and 1/8th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 18:57 UTC | Infinera Corp INFN · Entity 82602 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000052 · wf-form4_161550704913652.xml · derivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F2 · derivative.exercise_date: These RSUs vest as to one-third of the shares on the one-year anniversary of the vesting commencement date, which is April 5, 2021, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F2 · derivative.expiration_date: These RSUs vest as to one-third of the shares on the one-year anniversary of the vesting commencement date, which is April 5, 2021, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:54 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000030 · wf-form4_161534487795117.xml · derivative · entry 3 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F3 · derivative.exercise_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. F3 · derivative.expiration_date: These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:54 UTC | Infinera Corp INFN · Entity 82602 | Tax withholdingCommon Stock | 9,139 | $8.39 | $76,676.21 |
DisclosureSEC source: 0001138639-21-000030 · wf-form4_161534487795117.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,107,312 F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:54 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000030 · wf-form4_161534487795117.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,116,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| January 14, 2021 Filed Mar 11, 2021 18:54 UTC | Infinera Corp INFN · Entity 82602 | GrantRestricted Stock Units · Derivative | 14,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001138639-21-000050 · wf-form4_161550683398730.xml · derivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,550 Underlying: Common Stock · 14,550 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company"). F2 · derivative.exercise_date: On February 15, 2018, Dr. Welch was granted a PSU award for a target number of 45,833 shares of common stock that could become eligible to vest in three equal separate installments, subject to the achievement of certain performance criteria in each of the three different performance periods. The shares are eligible to vest based on the TSR performance of the Company in each performance period relative to that of the companies that comprise the S&P Networking Index. The performance objective related to this award was partially achieved for the third performance period, as determined by the Company's Compensation Committee per the terms of the original grant. As a result, 14,550 shares of common stock underlying this award will vest on May 5, 2021, subject to Dr. Welch's continued service to the Company through such date. F2 · derivative.expiration_date: On February 15, 2018, Dr. Welch was granted a PSU award for a target number of 45,833 shares of common stock that could become eligible to vest in three equal separate installments, subject to the achievement of certain performance criteria in each of the three different performance periods. The shares are eligible to vest based on the TSR performance of the Company in each performance period relative to that of the companies that comprise the S&P Networking Index. The performance objective related to this award was partially achieved for the third performance period, as determined by the Company's Compensation Committee per the terms of the original grant. As a result, 14,550 shares of common stock underlying this award will vest on May 5, 2021, subject to Dr. Welch's continued service to the Company through such date. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 19:07 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 16,993 | $10.02 | $170,331.03 |
DisclosureSEC source: 0001138639-20-000181 · wf-form4_160816366287184.xml · nonDerivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F7 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $10.00 to $10.06 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F6 · ownership.nature: These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member. Read SEC document |
| December 15, 2020 Filed Dec 16, 2020 19:07 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 259,849 | $10.15 | $2,637,233.49 |
DisclosureSEC source: 0001138639-20-000181 · wf-form4_160816366287184.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,091,451 F1 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F4 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $10.00 to $10.355 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F3 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 19:07 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 10,300 | $10.00 | $103,002.06 |
DisclosureSEC source: 0001138639-20-000181 · wf-form4_160816366287184.xml · nonDerivative · entry 3 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 16,993 F1 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F5 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $10.00 to $10.005 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F6 · ownership.nature: These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 19:07 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 40,151 | $10.00 | $401,510.00 |
DisclosureSEC source: 0001138639-20-000181 · wf-form4_160816366287184.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,351,300 F1 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F2 · price: This price represents the sale price of the shares sold in multiple transactions, each at a price of $10.00 per share. F3 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 49,917 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · derivative · entry 14 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,917 shares Expires 2021-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: This exercise was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F8 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 49,917 | $8.64 | $431,497.52 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 7 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,391,451 F2 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F4 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $8.63 to $8.70 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 49,917 | $8.58 | $428,287.86 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 6 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,441,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,535 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · derivative · entry 13 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,535 shares Expires 2021-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: This exercise was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F8 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 39,465 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · derivative · entry 12 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,465 shares Expires 2021-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: This exercise was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F8 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,833 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · derivative · entry 11 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,917 Underlying: Common Stock · 60,750 shares Expires 2021-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: This exercise was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F8 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 20,250 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · derivative · entry 10 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,250 shares Expires 2021-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · kind: This exercise was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F8 · derivative.exercise_date: This option is fully vested. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 112,083 | $8.64 | $968,879.08 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 5 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,391,451 F2 · kind: This sale was effected pursuant to Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F3 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $8.63 to $8.69 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 41,535 | $8.58 | $356,370.30 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 4 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,503,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 39,465 | $8.58 | $338,609.70 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 3 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,461,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 10,833 | $8.58 | $92,947.14 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,422,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:13 UTC | Infinera Corp INFN · Entity 82602 | Exercise / conversionCommon Stock | 20,250 | $8.58 | $173,745.00 |
DisclosureSEC source: 0001138639-20-000169 · wf-form4_160738639796347.xml · nonDerivative · entry 1 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,411,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 19:03 UTC | Infinera Corp INFN · Entity 82602 | SaleCommon Stock | 10,000 | $8.67 | $86,685.00 |
DisclosureSEC source: 0001138639-20-000167 · wf-form4_160695378465439.xml · nonDerivative · entry 2 Welch David F · CIK 0001399122 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 27,293 F2 · kind: This sale was made in connection with Dr. Welch's Rule 10b5-1 Trading Plan, which was adopted on November 20, 2019. F3 · price: This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $8.62 to $8.73 per share. Upon request by the staff of the Securities and Exchange Commission, Infinera Corporation (the "Company") or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price. F4 · ownership.nature: These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.